“Set aside panel’s recommendation”

Updated - November 17, 2021 06:46 am IST

Published - October 16, 2009 01:56 am IST - NEW DELHI

Wednesday (October 14) may well go down as the blackest day in Indian history, unless the government reverses the decision of the Genetic Engineering Approval Committee (GEAC) to recommend commercial release of Mahyco’s Bt brinjal.

Bt brinjal will impact the country’s food security, health, farming and environment in perpetuity, says a food safety analyst.

“We who know the details of the appraisal of the Mahyco-Monsanto safety dossier by four world renowned scientists [Seralini, Carman, Heinemann and Gurian-Sherman] cannot imagine the extent of the disaster that will unfold in India,” Aruna Rodrigues said from Mhow in Madhya Pradesh.

Quoting Seralini of France, Ms. Rodrigues said no long-term feeding studies for chronic toxicity had been conducted for Bt brinjal. These feeding studies only would help reveal tumours/cancers as they grow slowly. “The inescapable conclusion of these feeding studies is that they have been ‘engineered’ or designed to throw up ‘no significant differences’,” she said.

Ms. Rodrigues said Doug Gurian-Sherman of the Union of Concerned Scientists, a former scientist of the Environment Protection Agency, speaking about contamination from gene flow from Bt brinjal to wild brinjal relatives and domesticated varieties, reported that no gene-flow studies were done.

“The possibility of harm from gene flow has been widely recognised by many scientists. In the United States, this recognition has been a major factor in regulatory action restricting the commercialisation of GE crops (including cotton) with wild relatives. India is a centre of domestication and diversity for brinjal, and this adds additional concern.”

She said Jack Heinemann of the University of Canterbury, who assessed Mahyco’s molecular transformation methods, asserted that the company had failed at the elementary step of the safety study, analysing the insertion. “I have never seen less professionalism in the presentation and quality assurance of molecular data than in this study,” he was quoted as saying.

Ms. Rodrigues said the fact that the government accepted the principle that the seed-developing company itself should do safety testing of its own product and “trusted” it to do so invalidated the safety dossier.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.